Clinical Trial

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

Name: A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients. — clinical trial record (NCT07630545)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this trial is to learn if MTX325 can be developed as a potential disease-modifying treatment for Parkinson's Disease. Parts 1-4 complete, Part 5 (multiple doses in patients with Parkinson's Disease) in progress.

Protocol Amendment History 1 change

notable Trial sites expanded: 7 -> 18 locations 2026-07-24

Trial Details

NCT Number	NCT07630545
Lead Sponsor	Mission Therapeutics Collaborators: Michael J. Fox Foundation for Parkinson's Research, Parkinson's UK
Conditions	Parkinson's Disease (PD), Mild to Moderate Parkinson's Disease, Early Stage Parkinson's Disease
Enrollment	106 participants
Start Date	2023-11-30
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-12-27 (estimated)
Updated on ClinicalTrials.gov	2026-07-29